These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9166307

  • 1. Effects of first-trimester fluoxetine exposure on the newborn.
    Goldstein DJ, Corbin LA, Sundell KL.
    Obstet Gynecol; 1997 May; 89(5 Pt 1):713-8. PubMed ID: 9166307
    [Abstract] [Full Text] [Related]

  • 2. Effects of third trimester fluoxetine exposure on the newborn.
    Goldstein DJ.
    J Clin Psychopharmacol; 1995 Dec; 15(6):417-20. PubMed ID: 8748430
    [Abstract] [Full Text] [Related]

  • 3. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.
    Diav-Citrin O, Shechtman S, Weinbaum D, Wajnberg R, Avgil M, Di Gianantonio E, Clementi M, Weber-Schoendorfer C, Schaefer C, Ornoy A.
    Br J Clin Pharmacol; 2008 Nov; 66(5):695-705. PubMed ID: 18754846
    [Abstract] [Full Text] [Related]

  • 4. Birth outcomes in pregnant women taking fluoxetine.
    Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL.
    N Engl J Med; 1996 Oct 03; 335(14):1010-5. PubMed ID: 8793924
    [Abstract] [Full Text] [Related]

  • 5. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct 03; 8(43):157-9. PubMed ID: 11503843
    [Abstract] [Full Text] [Related]

  • 6. The fetal safety of fluoxetine: a systematic review and meta-analysis.
    Riggin L, Frankel Z, Moretti M, Pupco A, Koren G.
    J Obstet Gynaecol Can; 2013 Apr 03; 35(4):362-369. PubMed ID: 23660045
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Birth outcomes in pregnant women taking fluoxetine.
    Johnson GL.
    J Fam Pract; 1997 Jan 03; 44(1):32. PubMed ID: 9010368
    [No Abstract] [Full Text] [Related]

  • 10. Selective serotonin reuptake inhibitor exposure during early pregnancy and the risk of fetal major malformations: focus on paroxetine.
    Gentile S, Bellantuono C.
    J Clin Psychiatry; 2009 Mar 03; 70(3):414-22. PubMed ID: 19254517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
    Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.
    Birth Defects Res B Dev Reprod Toxicol; 2007 Feb 03; 80(1):18-27. PubMed ID: 17187388
    [Abstract] [Full Text] [Related]

  • 15. Treating depression in pregnancy.
    Robert E.
    N Engl J Med; 1996 Oct 03; 335(14):1056-8. PubMed ID: 8793933
    [No Abstract] [Full Text] [Related]

  • 16. Goldenhar syndrome associated with prenatal maternal Fluoxetine ingestion: Cause or coincidence?
    Farra C, Yunis K, Mikati M, Yazbeck N, Majdalani M, Awwad J.
    Birth Defects Res A Clin Mol Teratol; 2010 Jul 03; 88(7):582-5. PubMed ID: 20641101
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.